A Minnesota-based startup, Nurtured Nuts, is developing genetically modified peanuts that could reintroduce the popular snack into settings like airplanes, schools, and restaurants. The company aims to reduce the risk of severe allergic reactions, which affects millions of Americans and leads to widespread restrictions in public spaces.
Peanut allergies are the third-most common food allergen, impacting over six million Americans. Due to the potentially fatal nature of reactions, peanut-free policies are common in schools, hospitals, and on airlines. Nurtured Nuts is modifying peanut DNA using CRISPR technology to remove three key proteins—RH2, RH6, and RH7—that are known to trigger severe allergic responses.
The resulting peanuts are described as hypoallergenic, not entirely allergen-free. This means they are not intended for individuals with severe peanut allergies but are designed to be consumed in shared environments without posing the same level of risk to those with heightened sensitivities.
Regulatory Pathway
The company is currently conducting a clinical study at a major hospital to assess the allergic responses to its modified peanuts compared to conventional ones. In late 2025, the U.S. Department of Agriculture (USDA) approved Nurtured Nuts' application to cultivate its peanut seeds in Georgia. The next significant step involves obtaining approval from the Food and Drug Administration (FDA) to confirm the safety of the hypoallergenic nut for consumption, a process that could be completed as early as 2027.
Following potential FDA clearance, the company plans to introduce the peanuts to the market through partnerships with restaurants, cafeterias, and hospitals. The exact timeline remains uncertain as Nurtured Nuts engages in discussions with potential collaborators regarding product development and distribution strategies.
Potential Applications and Consumer Perception
Beyond direct consumption, the modified peanuts could be processed into various food products such as oil, flour, and butter. The peanut shells, also modified, may find use in cosmetics, insulation, or building materials. This versatility positions the product as a unique ingredient supplier for the food industry, particularly as demand for protein sources remains high amid rising meat prices.
However, the genetically modified nature of the peanuts could present a consumer challenge. Public wariness of GMOs persists, with some states enacting bans on lab-grown meat, citing consumer apprehension. Nurtured Nuts CEO Bryant Williams acknowledges this hurdle but suggests that evolving consumer trends may favor alternative products, citing the public's interest in plant-based meat alternatives as an example. Williams believes that the appeal of a solution to peanut allergens in public spaces could generate significant public support and gratitude.